Filtered By:
Vaccination: Influenza Vaccine
This page shows you your search results in order of date. This is page number 12.
Order by Relevance | Date
Total 6499 results found since Jan 2013.
CDC20 is a potential target gene to inhibit the tumorigenesis of MDCK cells
Biologicals. 2023 Aug 12;83:101697. doi: 10.1016/j.biologicals.2023.101697. Online ahead of print.ABSTRACTMDCK is currently the main cell line used for influenza vaccine production in culture. Previous studies have reported that MDCK cells possess tumorigenic ability in nude mice. Although complete cell lysis can be ensured during vaccine production, host cell DNA released after cell lysis may still pose a risk for tumorigenesis. Greater caution is needed in the production of human vaccines; therefore, the use of gene editing to establish cells incapable of forming tumors may significantly improve the safety of influenza v...
Source: Biologicals : Journal of the International Association of Biological Standardization - August 14, 2023 Category: Biotechnology Authors: Zhenbin Liu Mengyuan Pei Geng Liu Zhenyu Qiu Siya Wang Zilin Qiao Jiamin Wang Dongwu Jin Jiayou Zhang Kai Duan Xuanxuan Nian Zhongren Ma Xiaoming Yang Source Type: research
Parental acceptability of vaccinating young children against influenza and COVID-19
CONCLUSION: About 40 % of the parents were supportive of children's vaccinations against COVID-19 and influenza respectively (37 % and 42 %) in order to protect the vulnerable people around them. The media influences the decision to vaccinate especially when the level of education is low.PMID:37580209 | DOI:10.1016/j.vaccine.2023.08.005
Source: Vaccine - August 14, 2023 Category: Allergy & Immunology Authors: C éline Berthélémy Pascal Bouch é Zohra Lamiral Jean-Marc Boivin Source Type: research
CDC20 is a potential target gene to inhibit the tumorigenesis of MDCK cells
Biologicals. 2023 Aug 12;83:101697. doi: 10.1016/j.biologicals.2023.101697. Online ahead of print.ABSTRACTMDCK is currently the main cell line used for influenza vaccine production in culture. Previous studies have reported that MDCK cells possess tumorigenic ability in nude mice. Although complete cell lysis can be ensured during vaccine production, host cell DNA released after cell lysis may still pose a risk for tumorigenesis. Greater caution is needed in the production of human vaccines; therefore, the use of gene editing to establish cells incapable of forming tumors may significantly improve the safety of influenza v...
Source: Biologicals : Journal of the International Association of Biological Standardization - August 14, 2023 Category: Biotechnology Authors: Zhenbin Liu Mengyuan Pei Geng Liu Zhenyu Qiu Siya Wang Zilin Qiao Jiamin Wang Dongwu Jin Jiayou Zhang Kai Duan Xuanxuan Nian Zhongren Ma Xiaoming Yang Source Type: research
Parental acceptability of vaccinating young children against influenza and COVID-19
CONCLUSION: About 40 % of the parents were supportive of children's vaccinations against COVID-19 and influenza respectively (37 % and 42 %) in order to protect the vulnerable people around them. The media influences the decision to vaccinate especially when the level of education is low.PMID:37580209 | DOI:10.1016/j.vaccine.2023.08.005
Source: Vaccine - August 14, 2023 Category: Allergy & Immunology Authors: C éline Berthélémy Pascal Bouch é Zohra Lamiral Jean-Marc Boivin Source Type: research
CDC20 is a potential target gene to inhibit the tumorigenesis of MDCK cells
Biologicals. 2023 Aug 12;83:101697. doi: 10.1016/j.biologicals.2023.101697. Online ahead of print.ABSTRACTMDCK is currently the main cell line used for influenza vaccine production in culture. Previous studies have reported that MDCK cells possess tumorigenic ability in nude mice. Although complete cell lysis can be ensured during vaccine production, host cell DNA released after cell lysis may still pose a risk for tumorigenesis. Greater caution is needed in the production of human vaccines; therefore, the use of gene editing to establish cells incapable of forming tumors may significantly improve the safety of influenza v...
Source: Biologicals : Journal of the International Association of Biological Standardization - August 14, 2023 Category: Biotechnology Authors: Zhenbin Liu Mengyuan Pei Geng Liu Zhenyu Qiu Siya Wang Zilin Qiao Jiamin Wang Dongwu Jin Jiayou Zhang Kai Duan Xuanxuan Nian Zhongren Ma Xiaoming Yang Source Type: research
Tumorigenesis mechanism and application strategy of the MDCK cell line: A systematic review
Biologicals. 2023 Aug 11;83:101699. doi: 10.1016/j.biologicals.2023.101699. Online ahead of print.ABSTRACTInfluenza is an acute respiratory infectious disease caused by influenza virus that seriously endangers people's health. Influenza vaccination is the most effective means to prevent influenza virus infection and its serious complications. MDCK cells are considered to be superior to chicken embryos for the production of influenza vaccines, but the tumorigenicity of cells is a concern over the theoretical possibility of the risk of adverse events. The theoretical risks need to be adequately addressed if public confidence...
Source: Biologicals : Journal of the International Association of Biological Standardization - August 13, 2023 Category: Biotechnology Authors: Di Yang Lingwei Huang Jiamin Wang Huihao Wu Zhenbin Liu Ayimuguli Abudureyimu Zilin Qiao Source Type: research
Joint Prevalence of Influenza Preventive Behaviors Among Adults-United States, 2020
CONCLUSIONS: The overall joint prevalence was 8.5% (95% CI, 8.0-9.0). Prevalence was lower among older persons (vs younger); Hispanic and non-Hispanic Black persons (vs non-Hispanic White); current and former smokers (vs never smokers); postpartum women (vs neither pregnant nor postpartum); and those with a history of coronary heart disease, hypertension, stroke, diabetes, and chronic obstructive pulmonary disease (vs not having those respective condition). In addition to recommending annual vaccination, primary care providers might encourage sufficient sleep and adequate physical activity-especially among patients who hav...
Source: Primary Care - August 12, 2023 Category: Primary Care Authors: Bryant J Webber Anne G Wheaton Peng-Jun Lu Geoffrey P Whitfield Source Type: research
Vaccine patterns among patients diagnosed with Guillain-Barr é Syndrome and matched counterparts in a Medicare supplemental population, 2000-2020
Vaccine. 2023 Aug 10:S0264-410X(23)00947-7. doi: 10.1016/j.vaccine.2023.08.014. Online ahead of print.ABSTRACTSome vaccines have a small risk of Guillain-Barré Syndrome (GBS), a rare autoimmune disorder characterized by paralysis if untreated. The CDC's Advisory Committee on Immunization Practices (ACIP) guidelines do not consider GBS a precaution for future vaccines unless GBS developed within six weeks after a tetanus-toxoid-containing vaccine or influenza vaccine. Our goal was to describe vaccine patterns before and after GBS diagnosis. We matched each of 709 patients diagnosed with GBS from 2002 to 2020 with Medicare ...
Source: Vaccine - August 12, 2023 Category: Allergy & Immunology Authors: Samantha R Eiffert Til St ürmer Carolyn T Thorpe Rebecca Traub Sudha R Raman Virginia Pate Alan C Kinlaw Source Type: research
